Abstract
Here we report the genetic engineering and chemical modification of potato virus X (PVX) for the presentation of various peptides, proteins, and fluorescent dyes, or other chemical modifiers. Three different ways of genetic engineering are described and by these means, peptides are successfully expressed not only when the foot and mouth disease virus (FMDV) 2A sequence or a flexible glycine–serine linker is included, but also when the peptide is fused directly to the PVX coat protein. When larger proteins or unfavorable peptide sequences are presented, a partial fusion via the FMDV 2A sequence is preferable. When these PVX chimeras retain the ability to assemble into viral particles and are thus able to infect plants systemically, they can be utilized to inoculate susceptible plants for isolation of sufficient amounts of virus particles for subsequent chemical modification. Chemical modification is required for the display of nonbiological ligands such as fluorophores, polymers, and small drug compounds. We present three methods of chemical bioconjugation. For direct conjugation of small chemical modifiers to solvent exposed lysines, N-hydroxysuccinimide chemistry can be applied. Bio-orthogonal reactions such as copper-catalyzed azide–alkyne cycloaddition or hydrazone ligation are alternatives to achieve more efficient conjugation (e.g., when working with high molecular weight or insoluble ligands). Furthermore, hydrazone ligation offers an attractive route for the introduction of pH-cleavable cargos (e.g., therapeutic molecules).
Karin L. Lee and Kerstin Uhde-Holzem have contributed equally to this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Plummer EM, Manchester M (2010) Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3(2):174–196
Steinmetz NF (2010) Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 6:634
Pokorski JK, Steinmetz NF (2011) The art of engineering viral nanoparticles. Mol Pharm 8:29
Koenig RJ, Lesemann DE (1989) Potato virus X, potexvirus group. Assoc Appl Biol Warwick 354:1
Steinmetz NF, Mertens ME et al (2010) Potato virus X as a novel platform for potential biomedical applications. Nano Lett 10:305
Uhde K, Fischer R, Commandeur U (2005) Expression of multiple foreign epitopes presented as synthetic antigens on the surface of Potato virus X particles. Arch Virol 150:327
Uhde-Holzem K, Fischer R, Commandeur U (2007) Genetic stability of recombinant potato virus X virus vectors presenting foreign epitopes. Arch Virol 152:805
Marusic C, Rizza P et al (2001) Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 75:8434
Uhde-Holzem K, Schlösser V, Viazov S, Fischer R, Commandeur U (2010) Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9. J Virol Methods 166:12
Brennan FR, Jones TD et al (1999) Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 17:1846
Massa S, Simeone P et al (2008) Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein. Hum Gene Ther 19:354
Cruz SS, Chapman S et al (1996) Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci USA 93:6286
Donnelly ML, Hughes LE et al (2001) The ‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring ‘2A-like’ sequences. J Gen Virol 82:1027
Donnelly ML, Luke G et al (2001) Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’. J Gen Virol 82:1013
Werner S, Marillonnet S, Hause G, Klimyuk V, Gleba Y (2006) Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. Proc Natl Acad Sci USA 103:17678
Shukla S, Ablack AL et al (2012) Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle potato virus X. Mol Pharm 10(1):33–42
Brunel FM, Lewis JD et al (2010) Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett 10:1093
Dirksen A, Dawson PE (2008) Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling. Bioconjug Chem 19:2543
Wu Z, Chen K et al (2012) Development of viral nanoparticles for efficient intracellular delivery. Nanoscale 4:3567
Hong V, Presolski SI, Ma C, Finn MG (2009) Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation. Angew Chem Int Ed Engl 48:9879
Gomori G (1955) Preparation of buffers for use in enzyme studies. In: Colowick SP, Kaplan NO (eds) Methods in enzymology. Academic, New York, pp 138–143
Sivakumar K, Xie F et al (2004) A fluorogenic 1,3-dipolar cycloaddition reaction of 3-azidocoumarins and acetylenes. Org Lett 6:4603
Acknowledgements
This work was supported by Ohio Cancer Research Associates (to N.F.S.), Mt. Sinai Foundation (N.F.S.), NIH grant NCI R25 CA148052 Cancer Pharmacology training grant (K.L.L.).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Lee, K.L., Uhde-Holzem, K., Fischer, R., Commandeur, U., Steinmetz, N.F. (2014). Genetic Engineering and Chemical Conjugation of Potato Virus X. In: Lin, B., Ratna, B. (eds) Virus Hybrids as Nanomaterials. Methods in Molecular Biology, vol 1108. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-751-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-62703-751-8_1
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-750-1
Online ISBN: 978-1-62703-751-8
eBook Packages: Springer Protocols